000 01541 a2200445 4500
005 20250517012319.0
264 0 _c20151204
008 201512s 0 0 eng d
022 _a1549-490X
024 7 _a10.1634/theoncologist.2014-0418
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Linde, Myra E
245 0 0 _aBevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme.
_h[electronic resource]
260 _bThe oncologist
_cFeb 2015
300 _a107-8 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aDacarbazine
_xadministration & dosage
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aGlioblastoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aTemozolomide
700 1 _aVerhoeff, Joost J C
700 1 _aRichel, Dirk J
700 1 _avan Furth, Wouter R
700 1 _aReijneveld, Jaap C
700 1 _aVerheul, Henk M W
700 1 _aStalpers, Lukas J A
773 0 _tThe oncologist
_gvol. 20
_gno. 2
_gp. 107-8
856 4 0 _uhttps://doi.org/10.1634/theoncologist.2014-0418
_zAvailable from publisher's website
999 _c24527756
_d24527756